These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25560257)

  • 1. Synthesis, morphology and antifungal activity of nano-particulated amphotericin-B, ketoconazole and thymoquinone against Candida albicans yeasts and Candida biofilm.
    Randhawa MA; Gondal MA; Al-Zahrani AH; Rashid SG; Ali A
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2015; 50(2):119-24. PubMed ID: 25560257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.
    El-Azizi M; Farag N; Khardori N
    Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms.
    Delattin N; De Brucker K; Vandamme K; Meert E; Marchand A; Chaltin P; Cammue BP; Thevissen K
    J Antimicrob Chemother; 2014 Apr; 69(4):1035-44. PubMed ID: 24284780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of antifungal combinations against Candida albicans biofilms.
    Tobudic S; Kratzer C; Lassnigg A; Graninger W; Presterl E
    J Antimicrob Chemother; 2010 Feb; 65(2):271-4. PubMed ID: 19996142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of two systems for the determination of the sensitivity of yeasts to antifungal agents].
    de Montclos M; de Montclos H; Flandrois JP
    Pathol Biol (Paris); 1992 May; 40(5):495-9. PubMed ID: 1495833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effect of non-antifungal and antifungal agents on Candida isolates from the gastrointestinal tract.
    Siavoshi F; Tavakolian A; Foroumadi A; Hosseini NM; Massarrat S; Pedramnia S; Saniee P
    Arch Iran Med; 2012 Jan; 15(1):27-31. PubMed ID: 22208440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel assay of biofilm antifungal activity reveals that amphotericin B and caspofungin lyse Candida albicans cells in biofilms.
    DiDone L; Oga D; Krysan DJ
    Yeast; 2011 Aug; 28(8):561-8. PubMed ID: 21674619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: a modified XTT tetrazolium assay using synchronised C. albicans cells.
    Hawser S
    J Med Vet Mycol; 1996; 34(2):149-52. PubMed ID: 8732362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
    Morace G; Manzara S; Dettori G
    Chemotherapy; 1991; 37(1):23-31. PubMed ID: 2013239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigation of quantitative and species composition and antifungal drug susceptibility of yeasts isolated from patients with generalized periodontitis complicated by candidosis].
    Kutsyk RV; Pavliuk TD
    Mikrobiol Z; 2003; 65(5):26-9. PubMed ID: 14723159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effect of amphotericin B on Candida albicans, Candida glabrata and Candida parapsilosis biofilm formation.
    Prażyńska M; Gospodarek E
    Mycopathologia; 2014 Feb; 177(1-2):19-27. PubMed ID: 24436013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases.
    Tobudic S; Lassnigg A; Kratzer C; Graninger W; Presterl E
    Mycoses; 2010 May; 53(3):208-14. PubMed ID: 19298353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A disc plate assay for characterization of the effect of interaction between polyenes and azoles on growth of Candida albicans CA12.
    Cao B; Tsang PW; Tsang DN; Samaranayake LP; Wang J
    Microbios; 1996; 87(352):161-7. PubMed ID: 9050253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-biofilm activity of a sophorolipid-amphotericin B niosomal formulation against Candida albicans.
    Haque F; Sajid M; Cameotra SS; Battacharyya MS
    Biofouling; 2017 Oct; 33(9):768-779. PubMed ID: 28946803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yeasts isolated from nosocomial urinary infections: antifungal susceptibility and biofilm production.
    de Freitas AR; Baeza LC; Faria MG; Dota KF; Godoy Martínez P; Svidzinski TI
    Rev Iberoam Micol; 2014; 31(2):104-8. PubMed ID: 23810785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biofilm inhibition by Cymbopogon citratus and Syzygium aromaticum essential oils in the strains of Candida albicans.
    Khan MS; Ahmad I
    J Ethnopharmacol; 2012 Mar; 140(2):416-23. PubMed ID: 22326355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic study of antifungal activity of amphotericin B, 5-fluorocytosine and ketoconazole against clinical yeast isolates using liquid-phase turbidimetry.
    Dei-Cas E; Dujardin L; Ribeiro Pinto ME; Ajana F; Fruit J; Poulain D; Camus D; Vernes A
    Mycoses; 1991; 34(3-4):167-72. PubMed ID: 1749396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of different amphotericin B formulations from PMMA bone cements and their activity against Candida biofilm.
    Czuban M; Wulsten D; Wang L; Di Luca M; Trampuz A
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110406. PubMed ID: 31401462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic Antifungal Effect of Amphotericin B-Loaded Poly(Lactic-Co-Glycolic Acid) Nanoparticles and Ultrasound against Candida albicans Biofilms.
    Yang M; Du K; Hou Y; Xie S; Dong Y; Li D; Du Y
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670414
    [No Abstract]   [Full Text] [Related]  

  • 20. Acinetobacter sp. mediated synthesis of AgNPs, its optimization, characterization and synergistic antifungal activity against C. albicans.
    Nadhe SB; Singh R; Wadhwani SA; Chopade BA
    J Appl Microbiol; 2019 Aug; 127(2):445-458. PubMed ID: 31074075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.